Detalhe da pesquisa
1.
12-month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency.
Pituitary
; 16(3): 311-8, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22915288
2.
A randomized, double-blind study to assess the efficacy and safety of valtropin, a biosimilar growth hormone, in children with growth hormone deficiency.
Horm Res
; 68(6): 288-93, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17627092
3.
Comparative pharmacokinetics and pharmacodynamics of a new sustained-release growth hormone (GH), LB03002, versus daily GH in adults with GH deficiency.
J Clin Endocrinol Metab
; 91(8): 2926-30, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16720652
4.
Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD).
J Clin Endocrinol Metab
; 97(2): 400-7, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22162481
5.
Effects of once-weekly sustained-release growth hormone: a double-blind, placebo-controlled study in adult growth hormone deficiency.
J Clin Endocrinol Metab
; 96(6): 1718-26, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21411551
6.
Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiency.
Eur J Endocrinol
; 160(3): 349-55, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19074465